由于PARK7基因突变导致的帕金森症-静脉综合征
Alexander Calvano1, Dilara Bingoel1, Laura Beccaria1
1Department of Neurology, Philipps-University Marburg, Marburg, Germany.
Clinical parkinsonism & related disorders
|January 22, 2026
概括
一个新奇的PARK7基因突变在一个年轻女子身上引起了早期发病的帕金森症-呼吸阻塞症. 这凸显了基因测试对于诊断神经退行性疾病和理解DJ1的作用的重要性.
科学领域:
- 神经遗传学 神经遗传学
- 分子神经学分子神经学
- 运动障碍 运动障碍
背景情况:
- 帕金森症-静脉缩是一种复杂的神经疾病.
- 编码DJ-1的PARK7基因与神经保护和帕金森病的发病有关.
- 在PARK7中发生的基因突变会导致早期发病的疾病.
研究的目的:
- 报告一种新的同卵性PARK7突变.
- 描述患有这种突变的患者的临床表现.
- 为了强调DJ1在神经退行症中的作用.
主要方法:
- 一个年轻女子的临床病例描述.
- 基因分析以确定突变.
- 患者神经症状的表型特征.
主要成果:
- 在PARK7基因中发现了一种新型同卵性突变.
- 这位患者出现了早期发病,进展性帕金森症-静脉缩症.
- 这种综合征对多巴胺激素治疗的反应不佳.
- 在同卵性突变载体中观察到临床异质性.
结论:
- 新的PARK7突变可以导致早期发病的帕金森症-静脉缩症.
- 分子特征和详细的表型是诊断罕见的神经退行性疾病的关键.
- 了解DJ1的功能是解开神经退行机制的关键.
关键词:
DJ1 DJ1 DJ1 DJ1 DJ1 DJ1 DJ1 DJ1 DJ1 DJ1 DJ1 DJ1 DJ1遗传学 是一个遗传学.在PARK7中,我们可以找到PARK7.帕金森病是帕金森氏症的一种疾病.更多相关视频
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.9K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
2.2K
相关概念视频
Mutation, Gene Flow, and Genetic Drift
63.1K
In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
63.1K
Mutations
94.4K
Overview
94.4K
Mutations
44.0K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.0K
Viral Mutations
39.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.8K
Parkinson's Disease: Treatment
1.0K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Gene Therapy
27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
